Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.2091

-0.0081 (-3.73%)

At close: Feb 12, 2026, 4:00 PM EST

0.2197

+0.0106 (5.07%)

After-hours: Feb 12, 2026, 7:41 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
ViraxClear and ViraxVet	156.42K
ViraxClear and ViraxVet Growth	1727.11%

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
United Kingdom, Hong Kong, Singapore, China, British Virgin Islands	156.42K
United Kingdom, Hong Kong, Singapore, China, British Virgin Islands Growth	1727.11%